Monthly Prescribing Reference12d
Labeling for ADHD Med Qelbree Updated With Lactation, Pharmacodynamic Data
Credit: Supernus Qelbree is a selective norepinephrine reuptake inhibitor. The transfer of the drug into breastmilk was reported to be low. The prescribing information for Qelbree ® (viloxazine ...
Supernus announces U.S. FDA approved an update for label for Qelbree
Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has approved an update for the label for Qelbree to ...
Nasdaq11d
FDA Approves Qelbree Label For ADHD And Lactation
(RTTNews) - Supernus Pharmaceuticals, Inc. (SUPN), a biopharmaceutical company, announced on Monday that the U.S. Food and Drug Administration or FDA has approved an updated label for Qelbree or ...
Nasdaq11d
Supernus Pharmaceuticals Announces FDA Approval for Updated Qelbree Label Including New Pharmacodynamic Data and Lactation Information
Supernus Pharmaceuticals, Inc. announced that the FDA has approved an updated label for Qelbree (viloxazine extended-release capsules) to include new pharmacodynamic data, highlighting its ...